• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Webinar on FDA’s Safety Monitoring of Approved Vaccines

DATE:  July 13, 2010

TIME:  2:00 PM

LENGTH:  30 minutes

Did you know that FDA’s review of vaccine safety doesn’t stop once a vaccine is approved?  Why is it important to have different types of systems to perform safety surveillance for approved vaccines?

On Tuesday, July 13th, FDA hosted a webinar about the agency’s work to ensure the safety of vaccines.  Andrea Sutherland, MD, MPH, Msc, who is a medical officer and Special Assistant to the Director of the Division of Epidemiology in the Office of Biostatistics and Epidemiology in FDA’s Center for Biologics Evaluation and Research, provided an overview and answered questions about vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (or VAERS), and efforts underway to improve safety monitoring.  Currently, FDA is working with federal, international, academic, and health care partners to further improve its ability to evaluate the safety of vaccines throughout the lifecycle of products.

Watch the archived version of the Webinar: CBER VAERS Vaccine Safety

Download Presentation Slides (PDF - 103 KB)

Basics Question toggle Show all related FDA Basics Questions

-

How helpful was this information?

                               

Not HelpfulArrow pointing to the rightVery Helpful


Please limit your feedback to 1000 characters.

Please limit your feedback to 1000 characters.

If you would like to ask a specific question, please visit our "Contact Us" page for more information about how to contact FDA.

Please note that any information you submit may become public or subject to release under the Freedom of Information Act (FOIA). For more information, read about our privacy policies and the FOIA.

-